TG Branfalt

Vireo Health has acquired Massachusetts licensed cannabis company Mayflower Botanicals; it is Vireo’s first acquisition in a state with an adult-use program.

The FDA is planning a public hearing next month to consider the safety, manufacturing, product quality, marketing, labeling, and sale of federally regulated CBD products.

LA prosecutors and nonprofit tech organization Code for America are teaming up to help guide as many as 50,000 cannabis convicts down the path to expungement.

The new law authorizes the state treasurer to select financial institutions who will provide banking services via a competitive bidding process to state-legal cannabis companies.

Maryland cannabis operator Curio Wellness has withdrawn the lawsuit filed late last month against the state’s Medical Cannabis Commission over its plan to issue new cannabis licenses to minority-owned companies.

The deal, which is expected to be finalized in June, would give Origin House shareholders 0.8428 of Cresco stock for each share held.

Legislative leaders had packaged the medical cannabis and recreational bills together hoping to garner more ‘yes’ votes for legalization, but may need to take separate action to benefit medical patients if the adult-use bill continues to flounder.

At least one New York village has announced plans to sue the state government if lawmakers approve statewide legalization legislation.

Unlicensed dispensaries in Michigan have been given yet another extension for licensure after dispensary owners successfully argued they were only denied a license because the state erroneously recorded its tax payments.

Walgreens is the latest major pharmacy chain to announce it will carry hemp-derived CBD products.

A Massachusetts investigation aims to uncover whether or not two of the state’s large cannabis companies have thwarted state rules regarding the number of licenses that a single company can hold.

A piece of emergency legislation in Maine has passed into law, aligning the state’s definition of industrial hemp with language in the federal farm bill.

Guam lawmakers narrowly passed a legalization bill on Wednesday; the bill now goes to Gov. Lou Leon Guerrero for her final decision on legalizing cannabis in the U.S. territory.

The agreement will establish a new company, Houseplant, which plans to offer three strains – Houseplant Sativa, Houseplant Hybrid, and Houseplant Indica – over the coming months.

Maryland medical cannabis firm Curio is filing suit against the state Medical Cannabis Commission for allegedly violating its own rules by soliciting license applications without first completing a supply and demand survey.

In addition to the new legalization language being considered, the committee also advanced legislation to add opioid use disorder to the state’s medical cannabis qualifying conditions list.

The investment will span five years and will cover applications for basic science, clinical, health services, and policy cannabis research.

New legislation in Florida would establish rules for farmers and other businesses to cultivate, manufacture, and sell industrial hemp products.

Some 40 percent of U.S. adults who are 21 or older say they are interested in experimenting with CBD products.

A vote was expected after the legalization bill passed two legislative committees last week, but a number of dissenting Democratic senators means the vote would fail — for now.

A hemp bill has passed unanimously from the Idaho state House of Representatives to the Senate; lawmakers are anxious for a change in the face of hemp’s recent federal legalization.

The proposal could result in reduced tax rates for low-THC and/or hemp-derived products.

Louisiana enforcement officials are planning a crackdown on CBD products sourced from out-of-state hemp farms, despite hemp’s recent legalization via the 2018 farm bill.

The school — which offers courses covering all aspects of the cannabis industry — reported $1.125 million in revenues last year after just $360,000 the year prior.